Figure 3From: Low incidence of new biochemical and clinical hypogonadism following hypofractionated stereotactic body radiation therapy (SBRT) monotherapy for low- to intermediate-risk prostate cancerComparison of pre-treatment biochemical hypogonadism rates to those at up to 1 year following treatment.Back to article page